Skip to main navigation Investors News & Events Financials Stock Corporate Governance Resources Investor Relations Outset (Nasdaq: OM) is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Download Press Releases November 29, 2021 Tablo® Hemodialysis System Cartridge Receives FDA 510(k) Clearance Enabling Production in North America November 18, 2021 Outset Medical Named to Fast Company’s First-Ever List of the Next Big Things in Tech November 8, 2021 Outset Medical Launches Inaugural ESG Report > View All News View All Events November 16, 2021 at 1:40 PM PST Stifel 2021 Virtual Healthcare Conference November 3, 2021 at 2:00 PM PDT Outset Medical Q3 2021 Earnings Conference Call September 13, 2021 at 2:00 PM PDT Morgan Stanley 19th Annual Global Healthcare Conference > View All Events View All Quarterly Earnings Q3 2021 Earnings Event Earnings Release Form 10-Q Q2 2021 Earnings Event Earnings Release Form 10-Q > View All Earnings View All Read Our ESG Report Toolkit Print Page Email Alerts RSS Feeds Outset Medical 3052 Orchard Drive San Jose, CA 95134 Social Links > Footer Links Contact Us Privacy Policy © 2021 Outset Medical, Inc. All rights reserved. “Tablo” is a trademark of our company.